ADHD - Attention Deficit Disorder With Hyperactivity
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Plus TherapeuticsAUSTIN, TX
1 programIntermittent Theta Burst Stimulation to Right DLPFCN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2024
2025
2026
2027
Plus TherapeuticsIntermittent Theta Burst Stimulation to Right DLPFC
UNION therapeuticstPBM（active）
Clinical Trials (2)
Total enrollment: 60 patients across 2 trials
Brain Stimulation and Attention Control in Children With ADHD
Start: Sep 2025Est. completion: Jun 2026
N/AEnrolling By Invitation
An Intervention Study on Transcranial Photobiomodulation in Children With Attention Deficit Hyperactivity Disorder
Start: Dec 2024Est. completion: May 202760 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 60 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.